SCHEMBL6159133

SCHEMBL6159133

CCOC(=O)C(C)N1C(=O)C(N2C(=O)c3ccccc3C2=O)CCC(=O)N1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.46
ALDH1A1 P00352 7/20 0.39
DDB1 Q16531 4/20 0.39
CRBN Q96SW2 4/20 0.39
CHRM2 P08172 1/20 0.39
OPRM1 P35372 1/20 0.39
IKZF3 Q9UKT9 1/20 0.39
CYP1A2 P05177 1/20 0.39
TSHR P16473 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TP53 P04637 1/20 0.39
MDM2 Q00987 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAP1LC3B Q9GZQ8 1/20 0.37
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6158424 0.77 TP53 (0.37) ALDH1A1TSHRTP53MDM2MEN1
SCHEMBL7345149 0.75 MME (0.51) L3MBTL1ALDH1A1DDB1CRBNCHRM2
SCHEMBL24921828 0.74 DDB1 (0.41) L3MBTL1ALDH1A1DDB1CRBNCHRM2
SCHEMBL14294602 0.73 MAP1LC3B (0.42) L3MBTL1ALDH1A1DDB1CRBNCHRM2
SCHEMBL3595531 0.72 L3MBTL1 (0.40) L3MBTL1ALDH1A1DDB1CRBNCHRM2
SCHEMBL3595533 0.72 L3MBTL1 (0.40) L3MBTL1ALDH1A1DDB1CRBNCHRM2
SCHEMBL7459375 0.72 L3MBTL1 (0.39) L3MBTL1ALDH1A1DDB1CRBNCHRM2
SCHEMBL27861225 0.72 L3MBTL1 (0.39) L3MBTL1ALDH1A1DDB1CRBNCHRM2
SCHEMBL18923301 0.72 MAP1LC3B (0.41) L3MBTL1ALDH1A1DDB1CRBNCHRM2
SCHEMBL14294603 0.72 MAP1LC3B (0.41) L3MBTL1ALDH1A1DDB1CRBNCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1062210-B1 1,2-DIAZEPANE DERIVATIVES AS INTERLEUKIN-1BETA CONVERTING ENZYME INHIBITORS VERTEX PHARMA (US) 2005-06-01 EP disclosed
US-6426413-B1 SUCH AS (N-BENZYLOXYCARBONYL-HYDRAZINO)-ACETIC ACID TERT-BUTYL ESTER; FOR PREVENTING AND TREATING INTERLEUKIN-MEDIATED DISEASES, APOPTOSIS, AUTOIMMUNE DISEASES, BONE DISORDERS, PROLIFERATIVE DISORDERS, INFECTIONS, AND DEGENERATIVE DISEASES VERTEX PHARMACEUTICALS INCORPORATED 2002-07-30 US disclosed